These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25821229)

  • 21. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
    Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
    J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.
    Siddiqui KF; Amir M; Khan N; Rama Krishna G; Sheikh JA; Rajagopal K; Agrewala JN
    Clin Exp Immunol; 2015 Aug; 181(2):286-96. PubMed ID: 25845290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CD8+ cell noncytotoxic antiviral response (CNAR) to HIV in nosocomial HIV-infected individuals].
    Yuan L; Ma LY; Zang XH; Meng XD; Peng H; Zhao QB; Xing H; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):195-7. PubMed ID: 19031701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The proliferative response of HIV+ T-cells (CD4+ and CD8+) are severely suppressed via CD28 coactivation.
    Eylar EH; Báez I; Lefranc CE; Colón-Martínez SL; Rodríguez V; Yamamura Y; Rodriguez N
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):989-93. PubMed ID: 9449531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques.
    White AD; Sarfas C; West K; Sibley LS; Wareham AS; Clark S; Dennis MJ; Williams A; Marsh PD; Sharpe SA
    Clin Vaccine Immunol; 2015 Sep; 22(9):992-1003. PubMed ID: 26108288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
    Betts MR; Ambrozak DR; Douek DC; Bonhoeffer S; Brenchley JM; Casazza JP; Koup RA; Picker LJ
    J Virol; 2001 Dec; 75(24):11983-91. PubMed ID: 11711588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
    Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.
    Zaunders JJ; Geczy AF; Dyer WB; McIntyre LB; Cooley MA; Ashton LJ; Raynes-Greenow CH; Learmont J; Cooper DA; Sullivan JS
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1519-27. PubMed ID: 10580402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.
    Kovacs JA; Lempicki RA; Sidorov IA; Adelsberger JW; Sereti I; Sachau W; Kelly G; Metcalf JA; Davey RT; Falloon J; Polis MA; Tavel J; Stevens R; Lambert L; Hosack DA; Bosche M; Issaq HJ; Fox SD; Leitman S; Baseler MW; Masur H; Di Mascio M; Dimitrov DS; Lane HC
    J Clin Invest; 2005 Aug; 115(8):2139-48. PubMed ID: 16025158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16).
    Launay O; Surenaud M; Desaint C; Ben Hamouda N; Pialoux G; Bonnet B; Poizot-Martin I; Gonzales G; Cuzin L; Bourgault-Villada I; Lévy Y; Choppin J; Durier C
    Vaccine; 2013 Sep; 31(40):4406-15. PubMed ID: 23850610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cationic liposomes on BCG trafficking and vaccine-induced immune responses following a subcutaneous immunization in mice.
    Derrick SC; Yang A; Parra M; Kolibab K; Morris SL
    Vaccine; 2015 Jan; 33(1):126-32. PubMed ID: 25448108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.
    Lind A; Sommerfelt M; Holmberg JO; Baksaas I; Sørensen B; Kvale D
    Scand J Infect Dis; 2012 Aug; 44(8):566-72. PubMed ID: 22339485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccines. From Israel: a T-cell vaccine.
    TreatmentUpdate; 2005; 17(1):11-2. PubMed ID: 17228460
    [No Abstract]   [Full Text] [Related]  

  • 35. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
    Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
    IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery.
    Singh KP; Howard JL; Wild SP; Jones SL; Hoy J; Lewin SR
    Clin Immunol; 2007 Aug; 124(2):200-6. PubMed ID: 17574925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dynamics of CD4+ T-cell depletion in HIV disease.
    McCune JM
    Nature; 2001 Apr; 410(6831):974-9. PubMed ID: 11309627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current understanding in HIV immunopathology and treatment.
    Williams JP; Frater J
    QJM; 2012 Aug; 105(8):725-8. PubMed ID: 22294649
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune reconstitution inflammatory syndrome of the small bowel in a human immunodeficiency virus-negative patient.
    Daum S; Loddenkemper C; Schneider T
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):e27-8. PubMed ID: 17628330
    [No Abstract]   [Full Text] [Related]  

  • 40. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
    Hoft DF; Brown RM; Roodman ST
    J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.